241
Participants
Start Date
August 31, 2006
Primary Completion Date
December 31, 2008
Study Completion Date
December 31, 2008
Satavaptan
oral administration once daily
placebo
oral administration once daily
Sanofi-Aventis Administrative Office, Malvern
Sanofi-Aventis Administrative Office, San Isidro
Sanofi-Aventis Administrative Office, Macquarie Park
Sanofi-Aventis Administrative Office, Diegem
Sanofi-Aventis Administrative Office, Sarajevo
Sanofi-Aventis Administrative Office, São Paulo
Sanofi-Aventis Administrative Office, Sofia
Sanofi-Aventis Administrative Office, Laval
Sanofi-Aventis Administrative Office, Santiago
Sanofi-Aventis Administrative Office, Prague
Sanofi-Aventis Administrative Office, Paris
Sanofi-Aventis Administrative Office, Berlin
Sanofi-Aventis Administrative Office, Kuala Lumpur
Sanofi-Aventis Administrative Office, México
Sanofi-Aventis Administrative Office, Warsaw
Sanofi-Aventis Administrative Office, Bucharest
Sanofi-Aventis Administrative Office, Moscow
Sanofi-Aventis Administrative Office, Belgrade
Sanofi-Aventis Administrative Office, Singapore
Sanofi-Aventis Administrative Office, Barcelona
Sanofi-Aventis Administrative Office, Istanbul
Lead Sponsor
Sanofi
INDUSTRY